1
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Identification of an Autoinhibitory Region in the Activation Loop of the Mos Protein Kinase

&
Pages 3472-3479 | Received 16 Feb 1996, Accepted 03 Apr 1996, Published online: 29 Mar 2023

REFERENCES

  • Alessi, D. R., Y. Saito, D. G. Campbell, P. Cohen, G. Sithanandam, R. Rapp, A. Ashworth, D. J. Marshall, and S. Cowley. 1994. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 13:1610–1619.
  • Chou, P. Y., and G. D. Fasman. 1974. Prediction of protein conformation. Biochemistry 13:222–245.
  • Chou, P. Y., and G. D. Fasman. 1974. Conformational parameters for amino acids in helical β-sheet, and random coil regions calculated from proteins. Biochemistry 13:211–222.
  • Cooper, J. A., B. M. Sefton, and T. Hunter. 1983. Detection and quantification of phosphotyrosine in proteins. Methods Enzymol. 99:387–402.
  • Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841–852.
  • De Bondt, H. L., J. Rosenblatt, J. Jancarik, H. D. Jones, D. O. Morgan, and S.-H. Kim. 1993. Crystal structure of cyclin-dependent kinase 2. Nature (London) 363:595–602.
  • Freeman, R. S., S. M. Ballantyne, and D. J. Donoghue. 1991. Meiotic induction by Xenopus cyclin B is accelerated by coexpression with mosxe. Mol. Cell. Biol. 11:1713–1717.
  • Freeman, R. S., J. P. Kanki, S. M. Ballantyne, K. M. Pickham, and D. J. Donoghue. 1990. Effects of the v-mos oncogene on Xenopus development: meiotic induction in oocytes and mitotic arrest in cleaving embryos. J. Cell Biol. 111:533–541.
  • Freeman, R. S., A. N. Meyer, J. Li, and D. J. Donoghue. 1992. Phosphorylation of conserved serine residues does not regulate the ability of mosxe protein kinase to induce oocyte maturation or function as cytostatic factor. J. Cell Biol. 116:725–735.
  • Freeman, R. S., K. M. Pickham, J. P. Kanki, B. A. Lee, S. V. Pena, and D. J. Donoghue. 1989. Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes. Proc. Natl. Acad. Sci. USA 86:5805–5809.
  • Haccard, O., A. Lewellyn, R. S. Hartley, E. Erikson, and J. L. Maller. 1995. Induction of Xenopus oocyte meiotic maturation by MAP kinase. Dev. Biol. 168:677–682.
  • Haccard, O., B. Sarcevic, A. Lewellyn, R. Hartley, L. Roy, T. Izumi, E. Erikson, and J. L. Maller. 1993. Induction of metaphase arrest in cleaving Xenopus embryos by MAP kinase. Science 262:1262–1265.
  • Hanks, S. K., A. M. Quinn, and T. Hunter. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42–52.
  • Hannink, M., and D. J. Donoghue. 1985. Lysine residue 121 in the proposed ATP-binding site of the v-mos protein is required for transformation. Proc. Natl. Acad. Sci. USA 82:7894–7898.
  • Herzog, N. K., M. Nash, L. S. Ramagli, and R. B. Arlinghaus. 1990. v-mos protein produced by in vitro translation has protein kinase activity. J. Virol. 64:3093–3096.
  • Hu, S.-H., M. W. Parker, J. Y. Lel, M. C. J. Wilce, G. M. Benian, and B. E. Kemp. 1994. Insights into autoregulation from the crystal structure of twitchin kinase. Nature (London) 369:581–584.
  • Huang, W., D. S. Kessler, and R. L. Erikson. 1995. Biochemical and biological analysis of Mek1 phosphorylation site mutants. Mol. Biol. Cell 6:237–245.
  • Hubbard, S. R., L. Wei, L. Ellis, and W. A. Hendrickson. 1994. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature (London) 372:746–754.
  • Ito, M., V. Guerriero, X. M. Chen, and D. J. Hartshorne. 1991. Definition of the inhibitory domain of smooth muscle myosin light chain kinase by site-directed mutagenesis. Biochemistry 30:3498–3503.
  • Jeffrey, P. D., A. A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, and N. P. Pavletich. 1995. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature (London) 376:313–320.
  • Knighton, D. R., J. Zheng, L. F. Ten Eyck, V. A. Ashford, N.-H. Xuong, S. S. Taylor, and J. M. Sowadski. 1991. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253:407–414.
  • Knighton, D. R., J. Zheng, L. F. Ten Eyck, N.-H. Xuong, S. S. Taylor, and J. M. Sowadski. 1991. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253:414–420.
  • Kosako, H., Y. Gotoh, and E. Nishida. 1994. Mitogen-activated protein kinase kinase is required for the mos-induced metaphase arrest. J. Biol. Chem. 269:28354–28358.
  • Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande Woude, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966–970.
  • Masui, Y., and H. J. Clarke. 1979. Oocyte maturation. Int. Rev. Cytol. 57:185–282.
  • Masui, Y., and C. L. Markert. 1971. Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J. Exp. Zool. 177:129–146.
  • Maxwell, S. A., and R. B. Arlinghaus. 1985. Serine kinase activity associated with Moloney murine sarcoma virus-124-encoded p37mos. Virology 143:321–333.
  • Nebreda, A. R., and T. Hunt. 1993. The c-mos proto-oncogene protein kinase turns on and maintains the activity of MAP kinase, but not MPF, in cell-free extracts of Xenopus oocytes and eggs. EMBO J. 12:1979–1986.
  • Nurse, P. 1990. Universal control mechanism regulating onset of M-phase. Nature (London) 344:503–508.
  • Papkoff, J., E. A. Nigg, and T. Hunter. 1983. The transforming protein of Moloney murine sarcoma virus is a soluble cytoplasmic protein. Cell 33:161–172.
  • Posada, J., N. Yew, N. G. Ahn, G. F. Vande Woude, and J. A. Cooper. 1993. Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro. Mol. Cell. Biol. 13:2546–2553.
  • Puls, A., T. Proikas-Cezanne, B. Marquardt, F. Propst, and S. Stabel. 1995. Kinase activities of c-mos and v-mos proteins: a single amino acid exchange is responsible for constitutive activation of the 124 v-mos kinase. Oncogene 10:623–630.
  • Sagata, N., I. Daar, M. Oskarsson, S. D. Showalter, and G. F. Vande Woude. 1989. The product of the mos proto-oncogene as a candidate “initiator” for oocyte maturation. Science 245:643–646.
  • Sagata, N., M. Oskarsson, T. Copeland, J. Brumbaugh, and G. F. Vande Woude. 1988. Function of c-mos proto-oncogene product in meiotic matu ration in Xenopus oocytes. Nature (London) 335:519–525.
  • Sagata, N., N. Watanabe, G. F. Vande Woude, and Y. Ikawa. 1989. The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature (London) 342:512–518.
  • Singh, B., N. K. Herzog, J. Liu, and R. B. Arlinghaus. 1988. p37mos encoded by the HT-1 strain of Moloney murine sarcoma virus has an associated protein kinase activity. Oncogene 2:101–107.
  • Soderling, T. R. 1990. Protein kinases: regulation by autoinhibitory domains. J. Biol. Chem. 265:1823–1826.
  • Taylor, S. S., and E. Radzio-Andzelm. 1994. Three protein kinase structures define a common motif. Structure 2:345–355.
  • Taylor, S. S., J. Zheng, E. Radzio-Andzelm, D. R. Knighton, L. F. Ten Eyck, J. M. Sowadski, F. W. Herberg, and W. M. Yonemoto. 1993. cAMP-dependent protein kinase defines a family of enzymes. Philos. Trans. R. Soc. Lond. 340:315–324.
  • Van Beveren, C., F. Van Straaten, J. A. Galleshaw, and I. M. Verma. 1981. Nucleotide sequence of the genome of a murine sarcoma virus. Cell 27:97–108.
  • Van der Hoorn, F. A., E. Hulsebos, A. J. M. Berns, and H. P. J. Bloemers. 1982. Molecularly cloned c-mos (rat) is biologically active. EMBO J. 1:1313–1317.
  • Yew, N., M. L. Mellini, and G. F. Vande Woude. 1992. Meiotic initiation by the mos protein in Xenopus. Nature (London) 355:649–652.
  • Yew, N., M. Oskarsson, I. Daar, D. G. Blair, and G. F. Vande Woude. 1991. mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities. Mol. Cell. Biol. 11:604–610.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.